Skip to content

STUDY HELD TO SEE THE EFFECT OF KANAKSUNDAR RAS (TABLETS) WITH HINGU LAYER (LEPA) IN THE MANAGEMENT OF PAINFUL MENSTURATION.

â??A SINGLE ARM CLINICAL STUDY OF COMBINED EFFECT OF KANAKSUNDAR RAS WITH HINGU LEPA IN THE MANAGEMENT OF KASHTARTAVA (DYSMENORRHOEA)"

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038821
Enrollment
50
Registered
2021-12-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Dr Himakshi Tanwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) AGE GROUP FROM 15 TO 25 2) FEMALE PATIENTS WHO ARE HAVING KASHTARTAV(DYSMENORRHOEA) HAVING PAIN ONLY.

Exclusion criteria

Exclusion criteria: 1)UTERINE FIBROID. 2)STD 3)ATYARTAVA(MENORREHGIA) 4)RAKTAPRADRA(ABNORMAL UTERINE BLEEDING) 5)PATINT WITH OTHER SYSTEMIC DISORDERS LIKE DIABETES HTN ETC.

Design outcomes

Primary

MeasureTime frame
TO STUDY THE COMBINED EFFECT OF KANAKSUNDAR RAS WITH HINGU LEPA IN REDUCTION OF PAIN IN KASHTARTAV.Timepoint: FOR 2 CONSECUTIVE MENSTRUAL CYCLE.

Secondary

MeasureTime frame
TO OBSERVE ANY OTHER OUTCOMES OF KANAKSUNDAR RAS WITH HINGU LEPA IN KASHTARTAV.Timepoint: FOR 2 CONSECUTIVE MENSTRUAL CYCLE.

Countries

India

Contacts

Public ContactDr Himakshi Tanwar

Dr. D.Y. Patil College of Ayurved and Research Center, Sant Tukarm Nagar ,Pimpri, Pune

neetamahesekar19@gmail.com9822627092

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026